Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rathan Kumar

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia responseRathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, et al.
Blood Advances|January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic modelLotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
G3 (Bethesda, Md.)|November 7, 2023
A genome-wide overexpression screen reveals Mycobacterium smegmatis growth inhibitors encoded by mycobacteriophage HammyIsabel Amaya, Kaylia Edwards, Bethany M Wise, et al.
Blood|March 2, 2026
BET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHDRathan Kumar, Lotus Neidemire-Colley, Elizabeth Ar Garfinkle, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2025
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia responseRathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, et al.
Blood Advances|January 5, 2024
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic modelLotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, et al.
G3 (Bethesda, Md.)|November 7, 2023
A genome-wide overexpression screen reveals Mycobacterium smegmatis growth inhibitors encoded by mycobacteriophage HammyIsabel Amaya, Kaylia Edwards, Bethany M Wise, et al.
Blood|March 2, 2026
BET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHDRathan Kumar, Lotus Neidemire-Colley, Elizabeth Ar Garfinkle, et al.
Pageof 2